Recombinant Human ARIH2 293 Cell Lysate

• Cat.No.: ARIH2-8725HCL

Specification

• Description: Antigen standard for ariadne homolog 2 (Drosophila) (ARIH2) is a lysate prepared from HEK293T cells transiently transfected with a TrueORF gene-carrying pCMV plasmid and then lysed in RIPA Buffer. Protein concentration was determined using a colorimetric assay. The antigen control carries a C-terminal Myc/DDK tag for detection.
• Source: HEK 293 cells
• Species: Human
• Components: This product includes 3 vials: 1 vial of gene-specific cell lysate, 1 vial of control vector cell lysate, and 1 vial of loading buffer. Each lysate vial contains 0.1 mg lysate in 0.1 ml (1 mg/ml) of RIPA Buffer (50 mM Tris-HCl pH7.5, 250 mM NaCl, 5 mM EDTA, 50 mM NaF, 1% NP40). The loading buffer vial contains 0.5 ml 2X SDS Loading Buffer (125 mM Tris-Cl, pH6.8, 10% glycerol, 4% SDS, 0.002% Bromophenol blue, 5% beta-mercaptoethanol).
• Size: 0.1 mg
• Storage Instruction: Store at -80°C. Minimize freeze-thaw cycles. After addition of 2X SDS Loading Buffer, the lysates can be stored at -20°C. Product is guaranteed 6 months from the date of shipment.
• Applications: ELISA, WB, IP. WB: Mix equal volume of lysates with 2X SDS Loading Buffer. Boil the mixture for 10 min before loading (for membrane protein lysates, incubate the mixture at room temperature for 30 min). Load 5 ug lysate per lane.

Gene Information

• Gene Name: ARIH2 ariadne homolog 2 (Drosophila) [ Homo sapiens ]
• Official Symbol: ARIH2
• Synonyms: ARIH2; ariadne homolog 2 (Drosophila); ariadne (Drosophila) homolog 2; E3 ubiquitin-protein ligase ARIH2; all trans retinoic acid inducible RING finger; TRIAD1; ARI-2; protein ariadne-2 homolog; all-trans retinoic acid inducible RING finger; ARI2; FLJ10938; FLJ33921
• Gene ID: 10425
• mRNA Refseq: NM_006321
• Protein Refseq: NP_006312
• MIM: 605615
• UniProt ID: O95376
• Chromosome Location: 3p21
• Pathway: Adaptive Immune System, organism-specific biosystem; Antigen processing: Ubiquitination and Proteasome degradation, organism-specific biosystem; Class I MHC mediated antigen processing & presentation, organism-specific biosystem; Immune System, organism-specific biosystem
• Function: ligase activity; metal ion binding; nucleic acid binding; protein binding; ubiquitin-protein ligase activity; zinc ion binding

Reviews

01/21/2023

This flexibility ensures that the ARIH2 protein can address my specific research objectives efficiently.

08/12/2022

Their experienced team is dedicated to resolving any issues or challenges I may encounter during my experiments, providing prompt and effective solutions.

07/30/2022

the manufacturer's technical expertise can be advantageous to researchers.

02/16/2022

Its purity, stability, and consistency ensure reliable and reproducible results, giving me confidence in the integrity of my research findings.

01/30/2022

This versatility enables researchers to explore ARIH2's function and role in a range of biological processes, making it a valuable tool across diverse research fields.

12/07/2021

With their assistance, I can overcome obstacles and optimize my experimental setup.

01/03/2021

With the ARIH2 protein and the manufacturer's support, I am confident in obtaining accurate and meaningful results for my scientific investigations.

10/27/2020

In addition to the advantages of ARIH2 protein itself, the manufacturer can play a crucial role in supporting the research efforts.

04/16/2020

This quality control is essential for obtaining reliable and reproducible data, as any variability in protein quality can introduce confounding factors into experiments.

12/18/2017

They can offer guidance on experimental design, protocol optimization, and troubleshooting, helping researchers overcome any challenges encountered during their trials.

Q&As

Is there any evidence for the involvement of ARIH2 in cancer development?

Yes, ARIH2 has been implicated in cancer development and progression. Its dysregulation has been observed in several cancer types, and studies have shown its role in regulating the stability and activity of oncoproteins and tumor suppressors.

Are there any known substrates of ARIH2 protein?

ARIH2 has been shown to ubiquitinate various proteins, including NEDD8-conjugating enzyme UbcH7, p53, and the EphA2 receptor, among others.

Are there any known interacting partners of ARIH2?

Yes, ARIH2 interacts with various proteins, including the NEDD8-conjugating enzyme UbcH7, p53, and multiple components of the immune response pathway.

Does ARIH2 have any known disease associations?

Research has suggested that ARIH2 may be involved in the pathogenesis of certain diseases, including cancer and neurodegenerative disorders.

How does the ARIH2 protein carry out ubiquitin ligase activity?

ARIH2 functions as an E3 ubiquitin ligase by binding to the target protein and facilitating the transfer of ubiquitin from the E2 ubiquitin-conjugating enzyme to the target protein.

Does ARIH2 play a role in the immune response?

Yes, ARIH2 has been implicated in the regulation of immune responses. It is involved in the degradation of immune signaling proteins, such as IKKγ and TRAF3, thereby modulating the activation of immune pathways.

What future directions of research are being pursued regarding the ARIH2 protein?

Future research on ARIH2 aims to further elucidate its molecular mechanisms, identify additional substrates, explore its potential as a therapeutic target, and understand its role in various diseases.

What techniques are used to study the ARIH2 protein?

Researchers employ techniques such as gene expression analysis, protein-protein interaction studies, structural biology, and molecular genetics to investigate the ARIH2 protein.

What are the consequences of ARIH2-mediated protein ubiquitination?

Ubiquitination by ARIH2 can lead to proteasomal degradation of the target protein, resulting in regulation of cellular processes, such as cell cycle progression, DNA repair, and immune responses.

Are there any inhibitors or activators discovered for ARIH2?

Currently, there are no specific inhibitors or activators known for ARIH2. However, research efforts are underway to identify small molecules or compounds that can modulate its activity for potential therapeutic purposes.

Are there any therapeutic implications of targeting ARIH2?

Targeting ARIH2 has shown potential for therapeutic intervention, particularly in the fields of cancer treatment and neurodegenerative disease research. However, further studies are needed to fully understand its potential as a therapeutic target.